330 related articles for article (PubMed ID: 18078659)
21. Pioglitazone and bladder cancer: the pros and cons.
Panikar V
J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
[No Abstract] [Full Text] [Related]
22. Glitazones in the treatment of diabetes mellitus: clinical outcomes in large scale clinical trials.
Charbonnel B
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():19-20. PubMed ID: 18001315
[TBL] [Abstract][Full Text] [Related]
23. [Glitazones critically evaluated].
Schernthaner G
Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
[No Abstract] [Full Text] [Related]
24. The rosiglitazone controversy: the Indian perspective.
Mohan V; Joshi SR
J Assoc Physicians India; 2007 Jul; 55():477-80. PubMed ID: 17907495
[No Abstract] [Full Text] [Related]
25. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
[No Abstract] [Full Text] [Related]
26. [Too positive comment on glitazones].
Lindberg M
Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
[No Abstract] [Full Text] [Related]
27. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
Misbin RI
Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
[No Abstract] [Full Text] [Related]
28. Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study.
Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir S
J Eval Clin Pract; 2010 Dec; 16(6):1124-8. PubMed ID: 21176002
[TBL] [Abstract][Full Text] [Related]
29. The pluses of pioglitazone.
Meyers L
Diabetes Forecast; 2005 Sep; 58(9):39. PubMed ID: 16187433
[No Abstract] [Full Text] [Related]
30. Thiazolidinediones and cardiovascular risk: will the evidence so far available modify treatment strategies for type 2 diabetes?
Vaccaro O; Riccardi G
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):85-7. PubMed ID: 18280715
[No Abstract] [Full Text] [Related]
31. [Glitazones more than hypoglycemics in type 2 diabetes].
Sjöholm A
Lakartidningen; 2007 Oct 24-30; 104(43):3201-3. PubMed ID: 18018938
[No Abstract] [Full Text] [Related]
32. [The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].
Szymborska-Kajanek A; Strojek K
Kardiol Pol; 2006 Mar; 64(3):322-5; discussion 325-6. PubMed ID: 16583340
[No Abstract] [Full Text] [Related]
33. [Glitazone - mailing no 1. In response to DMW 49/2007].
Traut V
Dtsch Med Wochenschr; 2008 Feb; 133(6):261; author reply 262-3. PubMed ID: 18236356
[No Abstract] [Full Text] [Related]
34. [Glitazone - mailing no 3. In response to DMW 49/2007].
Gundel UF
Dtsch Med Wochenschr; 2008 Feb; 133(6):261-2; author reply 262-3. PubMed ID: 18236354
[No Abstract] [Full Text] [Related]
35. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
36. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
Fujimoto K; Hamamoto Y; Honjo S; Kawasaki Y; Mori K; Tatsuoka H; Matsuoka A; Wada Y; Ikeda H; Fujikawa J; Koshiyama H
Diabetes Res Clin Pract; 2013 Feb; 99(2):e21-3. PubMed ID: 23228390
[TBL] [Abstract][Full Text] [Related]
37. [Heart failure while taking glitazones--what do we know today?].
Halbritter R
Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255
[No Abstract] [Full Text] [Related]
38. Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.
Nagajothi N; Adigopula S; Balamuthusamy S; Velazquez-Cecena JL; Raghunathan K; Khraisat A; Singh S; Molnar J; Khosla S; Benatar D
Am J Ther; 2008; 15(6):506-11. PubMed ID: 19127132
[TBL] [Abstract][Full Text] [Related]
39. Drugs for type 2 diabetes.
Treat Guidel Med Lett; 2011 Aug; 9(108):47-54. PubMed ID: 21778966
[No Abstract] [Full Text] [Related]
40. Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetes.
Kahn SE; Zinman B
Diabetes Care; 2007 Jun; 30(6):1672-6. PubMed ID: 17351271
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
